Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901820061> ?p ?o ?g. }
- W2901820061 endingPage "586" @default.
- W2901820061 startingPage "580" @default.
- W2901820061 abstract ": Despite the great progress in the development of targeted therapies for different types of cancer utilizing monoclonal antibodies (e.g., cetuximab for colorectal cancer and head and neck cancer therapy), kinase inhibitors (e.g., sorafenib for kidney cancer and gastrointestinal stromal tumours therapy), and immunomodulatory treatments (e.g., nivolumab and pembrolizumab for melanoma therapy and lung cancer therapy), there is still a need to search for new, more effective treatments. : Integrins are responsible for intercellular adhesion and interaction with the cellular matrix. The function of integrins is related to the transduction of intracellular signals associated with adhesion, migration, cell proliferation, differentiation, and apoptosis. Molecules targeting integrins that lead to cancer cell death have been developed. The most advanced molecules studied in clinical trials are abituzumab, intetumumab and cilengitide. There are different groups of anti-integrin drugs: monoclonal antibodies (e.g., abituzumab) and other such as cilengitide, E7820 and MK-0429. These drugs have been evaluated in various cancer types. However, they have shown modest efficacy, and none of them have yet been approved for cancer treatment. Studies have shown that patient selection using biomarkers might improve the efficacy of anti-integrin cancer treatment. Many preclinical models have demonstrated promising results using integrin visualization for cancer detection and treatment efficacy monitoring; however, these strategies require further evaluation in humans." @default.
- W2901820061 created "2018-11-29" @default.
- W2901820061 creator A5005706056 @default.
- W2901820061 creator A5065544926 @default.
- W2901820061 date "2019-06-27" @default.
- W2901820061 modified "2023-10-15" @default.
- W2901820061 title "Integrins as A New Target for Cancer Treatment" @default.
- W2901820061 cites W1532497207 @default.
- W2901820061 cites W1576773659 @default.
- W2901820061 cites W1582963778 @default.
- W2901820061 cites W1603226294 @default.
- W2901820061 cites W1914498658 @default.
- W2901820061 cites W1931312556 @default.
- W2901820061 cites W1963936920 @default.
- W2901820061 cites W1970483666 @default.
- W2901820061 cites W1977125553 @default.
- W2901820061 cites W1989632399 @default.
- W2901820061 cites W1996348230 @default.
- W2901820061 cites W1996784808 @default.
- W2901820061 cites W1998384592 @default.
- W2901820061 cites W2001493281 @default.
- W2901820061 cites W2001753204 @default.
- W2901820061 cites W2013381560 @default.
- W2901820061 cites W2016464470 @default.
- W2901820061 cites W2016636097 @default.
- W2901820061 cites W2016650805 @default.
- W2901820061 cites W2026184890 @default.
- W2901820061 cites W2026742952 @default.
- W2901820061 cites W2034000571 @default.
- W2901820061 cites W2035183057 @default.
- W2901820061 cites W2039317622 @default.
- W2901820061 cites W2039496775 @default.
- W2901820061 cites W2044570850 @default.
- W2901820061 cites W2050384949 @default.
- W2901820061 cites W2060179431 @default.
- W2901820061 cites W2061912810 @default.
- W2901820061 cites W2065097700 @default.
- W2901820061 cites W2065452679 @default.
- W2901820061 cites W2072674959 @default.
- W2901820061 cites W2076271925 @default.
- W2901820061 cites W2079252535 @default.
- W2901820061 cites W2080208032 @default.
- W2901820061 cites W2081136348 @default.
- W2901820061 cites W2082313852 @default.
- W2901820061 cites W2087647833 @default.
- W2901820061 cites W2100363932 @default.
- W2901820061 cites W2101244168 @default.
- W2901820061 cites W2101922439 @default.
- W2901820061 cites W2110705886 @default.
- W2901820061 cites W2115044953 @default.
- W2901820061 cites W2115516828 @default.
- W2901820061 cites W2121235111 @default.
- W2901820061 cites W2121800941 @default.
- W2901820061 cites W2130643308 @default.
- W2901820061 cites W2142275262 @default.
- W2901820061 cites W2150789897 @default.
- W2901820061 cites W2153431854 @default.
- W2901820061 cites W2158580537 @default.
- W2901820061 cites W2159638184 @default.
- W2901820061 cites W2160686510 @default.
- W2901820061 cites W2162922037 @default.
- W2901820061 cites W2167107456 @default.
- W2901820061 cites W2168918180 @default.
- W2901820061 cites W2170483997 @default.
- W2901820061 cites W2232088318 @default.
- W2901820061 cites W2256678160 @default.
- W2901820061 cites W2257534801 @default.
- W2901820061 cites W2320817256 @default.
- W2901820061 cites W2327153295 @default.
- W2901820061 cites W2468147905 @default.
- W2901820061 cites W2470197067 @default.
- W2901820061 cites W2524907165 @default.
- W2901820061 cites W2584888670 @default.
- W2901820061 cites W2597806546 @default.
- W2901820061 cites W4242090519 @default.
- W2901820061 cites W4251025034 @default.
- W2901820061 cites W4252851641 @default.
- W2901820061 cites W4254732828 @default.
- W2901820061 doi "https://doi.org/10.2174/1871520618666181119103413" @default.
- W2901820061 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30451118" @default.
- W2901820061 hasPublicationYear "2019" @default.
- W2901820061 type Work @default.
- W2901820061 sameAs 2901820061 @default.
- W2901820061 citedByCount "19" @default.
- W2901820061 countsByYear W29018200612019 @default.
- W2901820061 countsByYear W29018200612020 @default.
- W2901820061 countsByYear W29018200612021 @default.
- W2901820061 countsByYear W29018200612022 @default.
- W2901820061 countsByYear W29018200612023 @default.
- W2901820061 crossrefType "journal-article" @default.
- W2901820061 hasAuthorship W2901820061A5005706056 @default.
- W2901820061 hasAuthorship W2901820061A5065544926 @default.
- W2901820061 hasConcept C121608353 @default.
- W2901820061 hasConcept C126322002 @default.
- W2901820061 hasConcept C143998085 @default.
- W2901820061 hasConcept C170493617 @default.
- W2901820061 hasConcept C195687474 @default.
- W2901820061 hasConcept C203014093 @default.